PD-1 inhibitor-augmented HAIC-TKI therapy in hepatocellular carcinoma with portal vein tumor thrombosis: real-world survival benefits, safety, and subgroup-specific efficacy by Fei Cao, Fei Cao, Fei Cao, Fei Cao, Chunyong Wen, Chunyong Wen, Chunyong Wen, Chunyong Wen, Yujia Wang, Yujia Wang, Yujia Wang, Yujia Wang, Hongtong Tan, Hongtong Tan, Hongtong Tan, Hongtong Tan, Shaohuan Hao, Jinbin Chen, Jinbin Chen, Jinbin Chen, Jinbin Chen, Shuanggang Chen, Shuanggang Chen, Shuanggang Chen, Shuanggang Chen, Lujun Shen, Lujun Shen, Lujun Shen, Lujun Shen, Lin Xie, Lin Xie, Lin Xie, Lin Xie, Han Qi, Han Qi, Han Qi, Han Qi, Tao Huang, Tao Huang, Tao Huang, Tao Huang, Yaojun Zhang, Yaojun Zhang, Yaojun Zhang, Yaojun Zhang, Zilin Huang, Zilin Huang, Zilin Huang, Zilin Huang

Get full text

Hepatic artery infusion of FOLFOX chemotherapy plus camrelizumab combined with sorafenib for advanced hepatocellular carcinoma in Barcelona Clinic Liver Cancer stage C (Double-IA-0... by Lujun Shen, Fei Cao, Ying Liu, Gulijiayina Nuerhashi, Letao Lin, Hontong Tan, Chunyong Wen, Yujia Wang, Shuanggang Chen, Hongliang Zou, Lin Xie, Weijun Fan

Get full text